Out-Licensing of Innovative Finished Dosage Forms
Midas Pharma offers a broad range of innovative finished dosage forms for various indications, including a reliable supply chain. Our fixed-dose combinations and optimized dosage forms enable our licensees and distribution partners to mark themselves off from the competition.
Our products cover a broad range of indication fields. These include:
- Cardiovascular system
- Antineoplastic and immunomodulatory agents
- Central nervous system
- Allergy and colds
- Anti-infectives for systemic use
We steadily expand our portfolio of products developed exclusively by or in cooperation with Midas. Midas has established itself as an expert in fixed-dose combinations which significantly improve patient compliance by substituting several individual drugs. In this process, we work together with renowned cooperation partners, all of whom are at least EU-GMP certified.
Further, we offer numerous additional products for which Midas is holding the exclusive mandate from its partners for out-licensing.